Invetech Convenes Session at Cell Therapy Europe 2011
01 March 2011
Robert Speziale, Invetech, will convene the opening session at CTS Europe 2011, to be held later this month in Maastricht, the Netherlands.
Mr. Speziale, in conjunction with key industry leaders, including Morrie Ruffin, Executive Director of the Alliance for Regenerative Medicine, Ronnda Bartels of Aastrom BioSciences and Robert Deans of Athersys will conduct a special pre-conference session involving a panel of industry players. The format will rely on stimulating discussion about Challenges, Opportunities, and Obstacles to commercial development, including "Automated Cell Processing in Fully Closed Consumables".
Panellists will share their first-hand experiences solving the unique challenges that cell therapy companies face as they progress from clinical trials into commercial production and engage delegates to question and comment on opportunities and obstacles to more companies achieving their commercial objectives.
Thursday 10 March 2011 at 9.30am
CTS Europe 2011
March 10-11 2011
Château St. Gerlach Maastricht, the Netherlands
Visit the CTS Europe 2011 website to learn more.
Further Press Information
Alan Morris, Phone: +613 9211 7815, Fax: +613 9211 7703. Media Inquiries.